SGA
CLVS
Sector Gamma AS’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-156,969
| Closed | -$915K | – | 31 |
|
|
2020
Q3 | $915K | Sell |
156,969
-196,116
| -56% | -$1.14M | 0.21% | 28 |
|
|
2020
Q2 | $2.38M | Sell |
353,085
-23,000
| -6% | -$155K | 0.49% | 32 |
|
|
2020
Q1 | $2.39M | Sell |
376,085
-32,540
| -8% | -$207K | 0.51% | 30 |
|
|
2019
Q4 | $4.26M | Sell |
408,625
-22,800
| -5% | -$238K | 0.68% | 32 |
|
|
2019
Q3 | $1.7M | Hold |
431,425
| – | – | 0.29% | 34 |
|
|
2019
Q2 | $6.42M | Buy |
431,425
+51,648
| +14% | +$768K | 1.03% | 27 |
|
|
2019
Q1 | $9.43M | Buy |
379,777
+44,200
| +13% | +$1.1M | 1.51% | 21 |
|
|
2018
Q4 | $6.03M | Buy |
335,577
+150,000
| +81% | +$2.69M | 1.01% | 26 |
|
|
2018
Q3 | $5.45M | Buy |
185,577
+11,685
| +7% | +$343K | 0.85% | 25 |
|
|
2018
Q2 | $7.91M | Buy |
173,892
+50,000
| +40% | +$2.27M | 1.31% | 22 |
|
|
2018
Q1 | $6.54M | Sell |
123,892
-27,100
| -18% | -$1.43M | 1.18% | 25 |
|
|
2017
Q4 | $10.3M | Buy |
150,992
+2,900
| +2% | +$197K | 1.73% | 22 |
|
|
2017
Q3 | $12.2M | Buy |
+148,092
| New | +$12.2M | 1.86% | 18 |
|